4//SEC Filing
Smith Kevin C. 4
Accession 0001235802-20-000104
CIK 0001492658other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:19 PM ET
Size
5.4 KB
Accession
0001235802-20-000104
Insider Transaction Report
Form 4
Smith Kevin C.
SVP, Quality and Regulatory
Transactions
- Sale
Ordinary Shares, par value EUR 0.03 per share
2020-08-17$30.12/sh−1,529$46,055→ 27,055 total
Footnotes (2)
- [F1]These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 3,161 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 14,540 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001734572
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:19 PM ET
- Size
- 5.4 KB